Joe W. Gray

99.9k citations

487 papers · 46.4k indexed · 19 hit papers · h-index 99

Impact in

Cancer Research top 0.02%
- Cancer Genomics and Diagnostics
Genetics top 0.02%
- Genomic variations and chromosomal abnormalities

Papers in

Structural Biology 10
Cancer Research 102
- Cancer Genomics and Diagnostics 74

Co-authors: Daniel Pinkel T. Straume Colin C. Collins Anne Kallioniemi Olli Kallioniemi Dan Pinkel Fred Waldman Damir Sudar
Journals: Cancer Research (34 papers)Cytometry (28 papers)Proceedings of the National Academy of Sciences (20 papers)Nature Genetics (14 papers)Genomics (11 papers)
Partner nations: United States United Kingdom Canada

In The Last Decade

Joe W. Gray

475 papers receiving 45.1k citations

Hit Papers

15 papers align trajectories log scale

Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment 2022 · 140 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2022 Nature Communications
2013 Cancer Cell
2013 Nature Medicine
2011 Nature Medicine
2008 eScholarship (California Digital Library)
2004 Proceedings of the National Academy of Sciences
2003 Science
2003 Nature Genetics
2001 Nature Genetics
1999 Cell
1999 Nature Genetics
1998 Nature Genetics
1998 Nature Genetics
1994 Proceedings of the National Academy of Sciences
1994 Genes Chromosomes and Cancer
1992 Science
1988 Proceedings of the National Academy of Sciences
1986 Proceedings of the National Academy of Sciences
1983 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Joe W. Gray

Since Specialization

Citations

This map shows the geographic impact of Joe W. Gray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe W. Gray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe W. Gray more than expected).

Fields of papers citing papers by Joe W. Gray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe W. Gray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe W. Gray. The network helps show where Joe W. Gray may publish in the future.

Co-authors

The 25 scholars most cited alongside Joe W. Gray, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joe W. Gray Line = papers co-authored together Joe W. Gray links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Genomic Alterations during the In Situ to Invasive Ductal Breast Carcinoma Transition Shaped by the Immune System Molecular Cancer Research ·Anne Trinh, Carlos R. Gil Del Alcazar, Sachet A. Shukla, Koei Chin, Young Hwan Chang, Guillaume Thibault, Jennifer Eng, Bojana Jovanović, C. Marcelo Aldaz, So Yeon Park, Joon Jeong, Catherine J. Wu, Joe W. Gray, Kornélia Polyák	2020	24
2	Bayesian Network Inference Modeling Identifies TRIB1 as a Novel Regulator of Cell-Cycle Progression and Survival in Cancer Cells Cancer Research ·Rina Gendelman, Heming Xing, Olga K. Mirzoeva, Claudia Ximena Garay Ramírez, Christina Curtis, Heidi S. Feiler, Paul McDonagh, Joe W. Gray, Iya Khalil, W. Michael Korn	2017	57
3	Targeted Treatment of Metastatic Breast Cancer by PLK1 siRNA Delivered by an Antioxidant Nanoparticle Platform Molecular Cancer Therapeutics ·Jingga Morry, Worapol Ngamcherdtrakul, Shenda Gu, Moataz Reda, David J. Castro, Thanapon Sangvanich, Joe W. Gray, Wassana Yantasee	2017	51
4	Pathway-Enriched Gene Signature Associated with 53BP1 Response to PARP Inhibition in Triple-Negative Breast Cancer Molecular Cancer Therapeutics ·Saima Hassan, Amanda Esch, Tiera Liby, Joe W. Gray, Laura M. Heiser	2017	27
5	c-Src Modulates Estrogen-Induced Stress and Apoptosis in Estrogen-Deprived Breast Cancer Cells Cancer Research ·Ping Fan, Obi L. Griffith, Fadeke A. Agboke, Pavana Anur, Grupo de pesquisa Lugares-Livro dimensões poéticas e materiais, Russell E. McDaniel, Karen Creswell, Sung Hoon Kim, John A. Katzenellenbogen, Joe W. Gray, V. Craig Jordan	2013	70
6	The Transcription Factor ZNF217 Is a Prognostic Biomarker and Therapeutic Target during Breast Cancer Progression Cancer Discovery ·Laurie E. Littlepage, Adam S. Adler, Hosein Kouros‐Mehr, Guiqing Huang, Jonathan Chou, Sheryl R. Krig, Obi L. Griffith, James E. Korkola, Kun Qu, Devon A. Lawson, Qing Xue, Mark D. Sternlicht, Gerrit J.P. Dijkgraaf, Paul Yaswen, Hope S. Rugo, Colleen Sweeney, Colin C. Collins, Joe W. Gray, Howard Y. Chang, Zena Werb	2012	54
7	A Central Role for RAF→MEK→ERK Signaling in the Genesis of Pancreatic Ductal Adenocarcinoma Cancer Discovery ·Eric A. Collisson, Christy L. Trejo, Jillian M. Silva, Shenda Gu, James E. Korkola, Laura M. Heiser, Roch‐Philippe Charles, Brian Rabinovich, Byron Hann, David Dankort, Paul T. Spellman, Wayne A. Phillips, Joe W. Gray, Martin McMahon	2012	219
8	Lrig1 Is an Estrogen-Regulated Growth Suppressor and Correlates with Longer Relapse-Free Survival in ERα-Positive Breast Cancer Molecular Cancer Research ·Sheryl R. Krig, Seth Frietze, Catalina Simion, Jamie K. Miller, Liliana E. Cervantes Sánchez, 蘆田雄一郎, Lakmal Kotelawala, Lihong Qi, Obi L. Griffith, Joe W. Gray, Kermit L. Carraway, Colleen Sweeney	2011	54
9	Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence Cancer Research ·Mary Jo Fackler, Christopher B. Umbricht, Danielle Williams, Pedram Argani, E Koffka, Vanessa F. Merino, Wei Wen Teo, Zhe Zhang, Peng Huang, S. S. LEE, Jeffrey R. Marks, Stephen P. Ethier, Joe W. Gray, Antonio C. Wolff, Leslie Cope, Saraswati Sukumar	2011	159
10	Immutable Functional Attributes of Histologic Grade Revealed by Context-Independent Gene Expression in Primary Breast Cancer Cells Cancer Research ·Shanaz H. Dairkee, Aejaz Sayeed, Sue De Vincentis, Stacey Champion, Zhenhang Meng, Lakshmi R. Jakkula, Heidi S. Feiler, Joe W. Gray, Dan H. Moore	2009	17
11	Yin Yang 1 Modulates Taxane Response in Epithelial Ovarian Cancer Molecular Cancer Research ·Noriomi Matsumura, Zhiqing Huang, Tsukasa Baba, Paula S. Lee, Jason C. Barnett, Seiichi Mori, Jeffrey T. Chang, Wen-Lin Kuo, Hushidar Kharas, Regina S. Whitaker, Joe W. Gray, Shingo Fujii, Andrew Berchuck, Susan K. Murphy	2009	48
12	Integrative Analysis of Cyclin Protein Levels Identifies Cyclin B1 as a Classifier and Predictor of Outcomes in Breast Cancer Clinical Cancer Research ·Roshan Agarwal, Crs S J Bretherton, Simen Myhre, Mark Carey, Ju‐Seog Lee, Jens Overgaard, Jan Alsner, Katherine Stemke‐Hale, Aňa Lluch, Richard M. Neve, Wen Lin Kuo, Thérese Sørlie, Ayşegül A. Şahin, Vicente Valero, Khandan Keyomarsi, Joe W. Gray, Anne‐Lise Børresen‐Dale, Gordon B. Mills, Bryan T. Hennessy	2009	111
13	A Human Breast Cell Model of Preinvasive to Invasive Transition Cancer Research ·Aylin Rizki, Valerie M. Weaver, Sunyoung Lee, Gabriela I. Rozenberg, Koei Chin, Connie A. Myers, A. Bednarek, Joni D. Mott, Jeremy R. Semeiks, Leslie R. Grate, Shahzad I. Mian, Alexander D. Borowsky, Roy A. Jensen, Michael O. Idowu, Fanqing Chen, David J. Chen, Ole W. Petersen, Joe W. Gray, Mina J. Bissell	2008	130
14	Amplification of MDS1/EVI1 and EVI1, Located in the 3q26.2 Amplicon, Is Associated with Favorable Patient Prognosis in Ovarian Cancer Cancer Research ·Meera Nanjundan, Yasuhisa Nakayama, Kwai Wa Cheng, John Lahad, Jinsong Liu, Karen W. Lu, Wen-Lin Kuo, Karen Smith‐McCune, David A. Fishman, Joe W. Gray, Gordon B. Mills	2007	110
15	Amplification of PVT1 Contributes to the Pathophysiology of Ovarian and Breast Cancer Clinical Cancer Research ·Yinghui Guan, Wen-Lin Kuo, Jackie L. Stilwell, Hirokuni Takano, Anna Lapuk, Jane Fridlyand, Jian‐Hua Mao, Mamie Yu, Melinda A. Miller, Jennifer L. Santos, Steve E. Kalloger, Joseph W. Carlson, David G. Ginzinger, S Celniker, Gordon B. Mills, David G. Huntsman, Joe W. Gray	2007	295
16	Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity Cancer Research ·Shuzhong Zhang, Katherine S. Lovejoy, James E. Shima, Leah L. Lagpacan, Yan Shu, Anna Lapuk, Ying Chen, Takafumi Komori, Joe W. Gray, Xin Chen, Stephen J. Lippard, Kathleen M. Giacomini	2006	340
17	Array-Based Comparative Genomic Hybridization Analysis Identified Cyclin D1 as a Target Oncogene at 11q13.3 in Nasopharyngeal Carcinoma Cancer Research ·Angela B. Hui, Kris- Tin Fleischer, F Laurette, Raymond King‐Yin Tsang, Ka‐Fai To, Xin‐Yuan Guan, Aso Yoichiro, 이인비, Vaishnu Dutt, C. Andrew van Hasselt, Wen-Lin Kuo, Joe W. Gray, Dolly P. Huang, Kwok Wai Lo	2005	89
18	An Integrated View of Copy Number and Allelic Alterations in the Cancer Genome Using Single Nucleotide Polymorphism Arrays Cancer Research ·Xiaojun Zhao, Cheng Li, J. Guillermo Paez, Koei Chin, Pasi A. Jänne, Elena García Barrecheguren, Luc Girard, John D. Minna, David C. Christiani, Chris Leo, Joe W. Gray, William R. Sellers, Matthew Meyerson	2004	401
19	Oncogene Expression and Genetic Background Influence the Frequency of DNA Copy Number Abnormalities in Mouse Pancreatic Islet Cell Carcinomas Cancer Research ·Jeffrey H. Hager, John Hodgson, Jane Fridlyand, Sujatmi Hariono, Joe W. Gray, Douglas Hanahan	2004	22
20	Induction of Tumors in Mice by Genomic Hypomethylation Science ·François Gaudet, John Hodgson, Amir Eden, Laurie Jackson‐Grusby, Jessica Dausman, Joe W. Gray, Heinrich Leonhardt, Rudolf Jaenisch Hit paper breakdown →	2003	1150

About Joe W. Gray

Joe W. Gray is a scholar working on Structural Biology, Cancer Research, Biophysics, Genetics and Molecular Biology, having authored 487 papers that have together received 46.4k indexed citations. Recurring topics across this work include Genomic variations and chromosomal abnormalities (99 papers), Cancer Genomics and Diagnostics (74 papers), Chromosomal and Genetic Variations (50 papers), Genomics and Chromatin Dynamics (49 papers), Gene expression and cancer classification (45 papers), Molecular Biology Techniques and Applications (42 papers), Cancer-related Molecular Pathways (29 papers) and Cell Image Analysis Techniques (29 papers). The work is most often cited by research in Cancer Research (10.8k citations), Genetics (12.1k citations), Oncology (11.5k citations), Molecular Biology (26.8k citations) and Cell Biology (3.9k citations). Joe W. Gray has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Daniel Pinkel, T. Straume, Colin C. Collins, Anne Kallioniemi, Olli Kallioniemi, Dan Pinkel, Fred Waldman, Damir Sudar, Wen-Lin Kuo and Richard Segraves. Their work appears in journals such as Cancer Research, Cytometry, Proceedings of the National Academy of Sciences, Nature Genetics and Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact